Key result
Stress echocardiography alters clinical management in ~42% of adults with congenital heart disease.
Why the study?
Although stress echocardiography is an established tool in acquired heart disease, its utility in adult congenital heart disease is not well documented and is omitted from most major ACHD guidelines.
Does stress echocardiography influence clinical management decisions in adults with congenital heart disease?
Observational (n=369)
No
Does stress echocardiography influence clinical management decisions in adults with congenital heart disease?
Stress echocardiography in adults with congenital heart disease is feasible and leads to changes in clinical management in 41.7% of patients, supporting its broader use despite current absence from most major ACHD guidelines.
Background Stress echocardiography is an established tool to guide clinical decision-making in adults with acquired heart disease. However, its utility in adult congenital heart disease (ACHD), a population requiring lifelong follow-up, particularly after childhood intervention, is not well documented and is not included in most major ACHD guidelines. Purpose To assess the indications and clinical impact of stress echocardiography in a contemporary ACHD population. Methods In this retrospective study we analysed consecutive patients, aged >16 years referred for stress echocardiography at our tertiary centre between January 2015 and December 2025 (n=369). Indications, stress and echocardiographic parameters, reasons for test termination, and impact on clinical management were recorded. Results Subjects were aged 43±16 years and 53.9% were female. Underlying diagnoses included left heart obstructive lesions (29.3%), complex CHD (28.7%), shunt lesions (21.7%), congenital coronary anomalies (8.4%), and right heart obstructive lesions (4.9%). Prior surgical repair was present in 70.2%, including repeat surgery in 29.3%, and 18.2% had prior percutaneous intervention. Sinus rhythm was present in 92.1%. Common indications were assessment of inducible ischaemia (40.7%), aortic stenosis severity (13.8%), right ventricular contractile reserve (11.9%), left ventricular contractile reserve (9.5%), and pulmonary stenosis severity (6.5%). Treadmill testing was performed in 60.2% (10.3±3.9 METS), semi-supine bicycle in 36.6% (99±34 Watts), and dobutamine stress in 3.3% (peak dose 30 µg/kg/min), achieving 85±15% of predicted target heart rate. ST depression occurred in 8.2%, occasional and frequent ventricular ectopy in 14.4% and 7.6%, respectively, and sustained ventricular arrhythmia requiring defibrillation in one patient. Tests were most commonly terminated due to fatigue (31.7%), dyspnoea (27.7%), or target heart rate achievement (20.3%). In those referred for inducible ischemia 2.7% showed a positive result, aortic stenosis gradient became significant in 23.5% and pulmonary stenosis gradient significant in 50% for each respective indication. Clinical management changed in 41.7% of cases (Figure 1), including initiation of new medication (10.6%), referral for congenital surgery (10%), congenital percutaneous intervention (7.6%), advanced imaging (6.8%), electrophysiology review (2.7%), coronary angiography (1.1%) and cardiac transplantation referral (1.1%). Conclusions Stress echocardiography is feasible in contemporary ACHD populations and provides clinically meaningful information that influences management decisions.
No takes yet. Share an insight, caveat, or question.
Ratwatte et al. (2026) conducted an observational in Adult congenital heart disease (ACHD) (n=369). Stress echocardiography was evaluated on Change in clinical management. Stress echocardiography in adults with congenital heart disease altered clinical management in 41.7% of cases, including new medication (10.6%) and surgical referral (10%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: